BridgeMD
New treatment option for Stroke
Official title Strategy Training for Optimizing Attention for Individuals With Spatial Neglect
ClinicalTrials.gov ID: NCT07331896
What this study is testing
- What it's testing
- It is common for individuals after stroke to have a cognitive perceptual impairment called unilateral spatial neglect (neglect). Individuals with neglect have difficulty paying attention to one side of their body or one side of the environment and therefore experience difficulty performing daily activities.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- had a stroke
- presence of neglect as determined by score of \<18 or 2 or more collisions on the Virtual Reality Lateralized Attention Test (VRLAT); score below...
- ≥18 years old
- lives within 30 miles of the University of Pittsburgh in a community dwelling.
You likely can't join if
- Boston Diagnostic Aphasia Examination (BDAE) Severity Scale score of 0
- dementia per medical record
- active major depressive disorder per medical record
- not willing to be videotaped
- subject is currently receiving rehabilitation therapy as part of their usual care
The study team makes the final eligibility decision.
Where it's taking place
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.